Population Genomics of Drug Response

American Journal of PharmacoGenomics

Volumn 4, Issue 2, 2004, Pages 73-82

  Halapi, Eva ^a   Stefansson, Kari ^a   Hakonarson, Hakon ^a  

^a DECODE GENETICS   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLOZAPINE; CORTICOSTEROID; DICOUMAROL; FLUVOXAMINE; ISONIAZID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MERCAPTOPURINE; SALBUTAMOL; STATINE DERIVATIVE; THEOPHYLLINE DERIVATIVE; TRASTUZUMAB; WARFARIN; ZILEUTON;

ASTHMA; BLEEDING; BLOOD TOXICITY; DISEASE PREDISPOSITION; DRUG RESPONSE; DRUG SENSITIVITY; FOUNDER EFFECT; GENE ISOLATION; GENE MAPPING; GENETIC LINKAGE; GENETIC VARIABILITY; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; PHARMACOGENOMICS; POPULATION GENETICS; PRIORITY JOURNAL; RELATIVE; REVIEW; SCHIZOPHRENIA; SIBLING;

ANIMALS; ASTHMA; CHROMOSOME MAPPING; GENETIC DISEASES, INBORN; GENOMICS; HUMANS; LINKAGE (GENETICS); PHARMACOGENETICS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POPULATION; SCHIZOPHRENIA;

EID: 2342435188     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404020-00002     Document Type: Review

References (102)

1. Kerem B, Rommens J, Buchanan J, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989 Sep 8; 245 (4922): 1073-80
2. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989 Sep 8; 245 (4922): 1066-73
3. Koenig M, Hoffman E, Bertelson C, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987 Jul 31; 50 (3): 509-17
4. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994 Oct 7; 266 (5182): 66-71
5. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995 Dec 21-28; 378 (6559): 789-92
6. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996 May; 13 (1): 117-9
7. Altmuller JPL, Fischer G, Scherb H, et al. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 2001 Nov; 69 (5): 936-50
8. Risch N. Searching for genetic determinants in the new millennium. Nature 2000 Jun 15; 405 (6788): 847-56
9. Cowles C, Joel N, Altshuler D, et al. Detection of regulatory variation in mouse genes. Nat Genet 2002 Nov; 32 (3): 432-7
10. Nadeau J. Modifier genes in mice and humans. Nat Rev Genet 2001 Mar; 2 (3): 165-74
11. Holmans P. Affected sib-pair methods for detecting linkage to dichotomous traits: review of the methodology. Hum Biol 1998 Dec; 70 (6): 1025-40
12. Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8 (10): 1913-23
13. Arcos-Burgos M, Muenke M. Genetics of population isolates. Clin Genet 2002 Apr; 61 (4): 233-47
14. Hakonarson H, Gulcher J, Stefansson K. deCODE genetics, Inc. Pharmacogenomics 2003 Mar; 4 (2): 209-15
15. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997 Nov; 61 (5): 1179-88
16. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001 Jul; 69 (1): 124-37
17. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant or not? Hum Mol Genet 2002 Oct 1; 11 (20): 2417-23
18. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999 Jun; 22 (2): 139-44
19. Chakravarti A. Population genetics: making sense out of sequence. Nat Genet 1999 Jan; 21 (1 Suppl.): 56-60
20. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996 Sep 13; 273 (5281): 1516-7
21. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003 Mar; 33 Suppl. 1: 228-37
22. Patil N, Berno AJ, Hinds DA, et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001 Nov 23; 294 (5547): 1719-23
23. Gabriel S, Schaffner S, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002 Jun 21; 296 (5576): 2225-9
24. Ardlie K, Kruglyak L, Seilestad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002 Apr; 3 (4): 299-309
25. Glazier A, Nadeau J, Aitman T. Finding genes that underlie complex traits. Science 2002 Dec 20; 298 (5602): 2345-9
26. Lander ER, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995 Nov; 11 (3): 241-7
27. Hastbacka J, de la Chapelle A, Kaitila I, et al. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet 1992 Nov; 2 (3): 204-11
28. Jorde L, Watkins W, Viskochil D, et al. Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping. Am J Hum Genet 1993 Nov; 53 (5): 1038-50
29. Mohlke K, Lange E, Valle T, et al. Linkage disequilibrium between microsatellite markers extends beyond 1cM on chromosome 20 in Finns. Genome Res 2001 Jul; 11 (7): 1221-611
30. Kong A, Gudbjartsson D, Sainz J, et al. A high-resolution recombination map of the human genome. Nat Genet 2002 Jul; 31 (3): 241-7
31. Weber J. The Iceland map. Nat Genet 2002 Jul; 31 (3): 225-6
32. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet 2002 Mar; 70 (3): 593-603
33. Gudmundsson G, Matthiasson SE, Arason H, et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet 2002 Mar; 70 (3): 586-92
34. Hakonarson H, Bjornsdottir U, Halapi E, et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet 2002 Sep; 71 (3): 483-91
35. Hicks A, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002 Nov; 52 (5): 549-55
36. Ingvarsson T, Stefansson SE, Gulcher JR, et al. A large Icelandic family with early osteoarthritis of the hip associated with a susceptibility locus on chromosome 16p. Arthritis Rheum 2001 Nov; 44 (11): 2548-55
37. Karason A, Gudjonsson JE, Upmanyu R, et al, A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 2003 Jan; 72 (1): 125-31
38. Kristjansson K, Manolescu A, Kristinsson A, et al. Linkage of essential hypertension to chromosome 18q. Hypertension 2002 Jun; 39 (6): 1044-9
39. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002 Oct; 71 (4): 877-92
40. Thorgeirsson TE, Oskarsson H, Desnica N, et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet 2003 May; 72 (5): 1221-30
41. Stefansson S, Jonsson H, Ingvarsson T, et al. Genomewide scan for hand osteoarthritis: a novel mutation in Matrilin-3. Am J Hum Genet 2003 Jun; 72 (6): 1448-59
42. deCODE genetics. Decoding the language of life [online]. Available from URL: http://www.decode.com [Accessed 2004 Mar 23]
43. Harrison P, Owen M. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003 Feb 1; 361 (9355): 417-9
44. Cloninger C. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci U S A 2003 Oct 15; 99 (21): 13365-7
45. Goff D, Coyle J. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001 Sep; 158 (9): 1367-77
46. Blouin J, Dombroski B, Nath S, et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998 Sep; 20 (1): 70-3
47. Gurling H, Kalsi G, Brynjolfson J, et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001 Mar; 68 (3): 661-73
48. Kaufmann C, Suarez B, Malaspina D, et al. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998 Jul 10; 81 (4): 282-9
49. Kendler K, MacLean C, O'Neill F, et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 1996 Dec; 153 (12): 1534-40
50. Pulver A, Lasseter V, Kasch L, et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995 Jun 19; 60 (3): 252-60
51. Badner J, Gershon E. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7 (4): 405-11
52. Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003 Jan; 72 (1): 83-7
53. Straub R, Jiang Y, MacLean C, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002 Aug; 71 (2): 337-48
54. Straub R, MacLean C, Ma Y, et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 2002; 7 (6): 542-59
55. Faraone S, Skol A, Tsuang D, et al. Linkage of chromosome 13q32 to schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet 2002 Aug 8; 114 (6): 598-604
56. Benson M, Newey S, Martin-Rendon E, et al. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001 Jun 29; 276 (26): 24232-41
57. Berrettini W. Progress and pitfalls: bipolar molecular linkage studies. J Affect Disord 1998 Sep; 50 (2-3): 287-97
58. Pare C, Mack J. Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J Med Genet 1971 Sep; 8 (3): 306-9
59. Blakely R. Physiological genomics of antidepressant targets: keeping the periphery in mind. J Neurosci 2001 Nov 1; 21 (21): 8319-23
60. Serretti A. Pharmacogenetics in affective disorders. Eur J Pharmacol 2002 Mar 8; 438 (3): 117-28
61. Scharfetter J, Chaudhry H, Homik K, et al. Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients. Eur Neuropsychopharmacol 1999 Dec; 10 (1): 17-20
62. Malhotra A, Goldman D, Buchanan R, et al. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Mol Psychiatry 1998 Jan; 3 (1): 72-5
63. Cohen B, Ennulat D, Centorrino F, et al. Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology (Berl) 1999 Jan; 141 (1): 6-10
64. Hwu H, Hong C, Lee Y, et al. Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 1998 Sep 15; 44 (6): 483-7
65. Arranz M, Collier D, Sodhi M, et al. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995 Jul 29; 346 (8970): 281-2
66. Arranz M, Munro J, Owen M, et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 1998 Jan; 3 (1): 61-6
67. Birkett J, Arranz M, Munro J, et al. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 2000 Jun 26; 11 (9): 2017-20
68. Mohn A, Gainetdinov R, Caron M, et al. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999 Aug 20; 98 (4): 427-36
69. Van Eerdewegh P, Little R, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002 Jul 25; 418 (6896): 426-30
70. Xu J, Meyers DA, Ober C, et al. Genome-wide screen and identification of gene-gene interactions for asthma-susceptibility loci in three US populations: collaborative study on the genetics of asthma. Am J Hum Genet 2001 Jun; 68 (6): 1437-46
71. Palmer L, Silverman E, Weiss S, et al. Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002 Apr 1; 165 (7): 861-6
72. Tan S, Hall I, Dewar J, et al. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997 Oct 4; 350 (9083): 995-9
73. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1999 Mar; 8 (3): 334-9
74. Martinez F, Graves P, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997 Dec 15; 100 (12): 3184-8
75. Israel E, Drazen J, Liggett S, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000 Jul; 162 (1): 75-80
76. Samuelsson B, Dahlen S, Lindgren J, et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987 Sep 4; 237 (4819): 1171-6
77. Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999 Jun; 22 (2): 168-70
78. In K, Asano K, Beier D, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997 Mar 1; 99 (5): 1130-7
79. Silverman E, Du J, De Sanctis G, et al. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am J Respir Cell Mol Biol 1998 Aug; 19 (2): 316-23
80. Sampson A, Siddiqui S, Buchanan D, et al. Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000 Oct; 55 Suppl. 2: S28-31
81. Lam B, Austen K. Leukotriene C-4 synthase: a pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes. Am J Respir Crit Care Med 2000 Feb; 161 Suppl.: S16-9
82. Aithal G, Day C, Kesteven P, et al. Association of polymorphisms in the cytochrome 450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999 Feb 27; 353 (9154): 717-21
83. Christodoulou C, Klouvas G, Pateli A, et al. Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer. Anticancer Res 2003 Jan-Feb; 23 (1B): 737-44
84. McLeod H, Siva C. The thiopurine S-methyltransferase gene locus: implications for clinical pharmacogenomics. Pharmacogenomics 2002 Jan; 3 (1): 89-98
85. McLeod H, Krynetski E, Relling M, et al. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000 Apr; 14 (4): 567-72
86. Ordovas J, Lopez-Miranda J, Perez-Jimenez F, et al. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis 1995 Mar; 113 (2): 157-66
87. Smeraldi E, Zanardi R, Benedetti F, et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998 Nov; 3 (6): 508-11
88. Yu Y, Tsai S, Chen T, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002; 7 (10): 1115-9
89. Arranz M, Munro J, Birkett J, et al. Pharmacogenetic prediction of clozapine response. Lancet 2000 May 6; 355 (9215): 1615-6
90. Fellay J, Marzolini C, Meaden E, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002 Jan 5; 359 (9300): 30-6
91. Smith B. Approaches to breast-cancer staging. N Engl J Med 2000 Feb 24; 342 (8): 580-1
92. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000 Feb 24; 342 (8): 525-33
93. Donckier J, Roelants V, Pochet J. Staging of non-small-cell lung cancer with positron-emission tomography [letter]. N Engl J Med 2000 Nov 23; 343 (21): 1572
94. Slamon D, Clark G, Wong S, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987 Jan 9; 235 (4785): 177-82
95. Slamon D, Godolphin W, Jones L, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989 May 12; 244 (4905): 707-12
96. Hynes N. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 1993 Feb; 4 (1): 19-26
97. Borg A, Tandon A, Sigurdsson H, et al. HER2/neu amplification predicts poor survival in node positive patients. Cancer Res 1990 Jul 15; 50 (14): 4332-7
98. Farabegoli F, Ceccarelli C, Santini D, et al. c-erbB-2 overexpression in amplified and non-amplified breast carcinoma samples. Int J Cancer 1999 Jun 21; 84 (3): 273-7
99. Krynetski E, Tai H, Yates C, et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996 Aug; 6 (4): 279-90
100. Bamberger C, Bamberger A, de Castro M, et al. Glucocorticoid receptor, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995 Jun; 95 (6): 2435-41
101. Sher E, Leung D, Surs W, et al. Steroid-resistant asthma: cellular mechanisms contributing to inadequate responses to glucocorticoid therapy. J Clin Invest 1995 Jan; 93 (1): 33-9
102. Hakonarson H, Bjornsdottir U, Halapi E, et al. Pharmacogenomics study predicts glucocortecoid responsiveness with high accuracy [abstract]. Am J Hum Genet 2001 Oct; 69 (4): 1366